Comparing the dissolution rates and pellet fine structure of branded Zovirax® with three similar acyclovir generic products marketed across the world, all containing the same API itraconazole. Raman spectroscopy revealed recrystallizing API slowed the dissolution rate.
If scientific literature indicates that elements are not likely to be present in drug product components, and no additional elements are added…
It is typical to encounter a restricted number of APIs during the initial stages of drug development. This limitation hinders the swift…
FormaDose® Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led…
This document provides both a high-level overview of Hycon’s stand-alone small molecule analytical services, and a detailed list of services organized by…
An array of advanced technologies at your disposal to address your molecule’s challenges and processing hurdles effectively, achieving the optimal dosage form.